The Modern FDA | GenomeWeb

The Modern FDA

Andrew von Eschenbach, the former FDA commissioner, is now an advisor at Newt Gingrinch's Center for Health Transformation, reports the Wall Street Journal's Health Blog. He will lead a project that aims to modernize FDA by increasing its effectiveness and to speed the approval of new drugs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."